1. |
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national. Committee on prevention, detection, evaluation, and treatment of high blood pressure:the JNC 7 report[J]. JAMA, 2003, 289(19):2560-2572.
|
2. |
National Institute for Health and Clinical Excellence. Hypertension:the clinical management of primary hypertension in adults[EB/OL]. (2011-08-13)[2012-05-05]. http://www.nice.org.uk/nicemedia/live/13561/56008/56008.pdf.
|
3. |
中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志, 2011, 39(7):579-616.
|
4. |
林金秀, 谢私.正常高值血压的治疗观点[J].中华高血压杂志, 2007, 15(增刊):8-10.
|
5. |
Ren J, Grundy SM, Liu J, et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese:the results of a 15-year Chinese Multi-Provincial Cohort Study (CMCS)[J]. Atherosclerosis, 2010, 211(1):327-332.
|
6. |
He S, Wang S, Chen X, et al. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus:15-year prospective study in a general population[J]. Metabolism, 2012, 61(1):30-36.
|
7. |
刘冰, 李卫, 胡泊,等.中国35-40岁人群正常高值血压检出率及影响因素分析[J].中华高血压杂志, 2010, 18(2):187-192.
|
8. |
Mainous AG, Everett CJ, Liszka H, et al. Prehypertension and mortality in a nationally representative cohort[J]. Am J Cardiol, 2004, 94(12):1496-1500.
|
9. |
吴寿岭, 张子强, 宋胜斌.正常高值血压人群转归及其影响因素[J].中华心血管病杂志, 2010, 38(5):415-419.
|
10. |
Grotto I, Grossman E, Huerta M, et al. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults[J]. Hypertension, 2006, 48(2):254-259.
|
11. |
Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study:a cohort study[J]. Lancet, 2001, 358(9294):1682-1686.
|
12. |
He S, Chen X. Prehypertension should be considered a special blood pressure phase[J]. Hypertens Res, 2012, 35(5):561-562.
|
13. |
Wu S, Huang Z, Yang X, et al. Cardiovascular events in a prehypertensive Chinese population:four-year follow-up study[J].Int J Cardiol, 2013, 167(5):2196-2199.
|
14. |
吴寿岭,钟吉文,王丽晔,等.正常高值血压人群中心脑血管事件发生情况及影响因素[J].中华高血压杂志, 2012, 20(3):247-251.
|
15. |
Angela M, Tian Hu, Carrie L, et al. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension:a Meta-analysis[J]. JAMA, 2011, 305(9):913-922.
|
16. |
Lüders S, Schrader J, Berger J, et al. The PHARAO study:prevention of hypertension with the angiotensinconverting enzyme inhibitor ramipril in patients with high-normal blood pressure:a prospective, randomized, controlled prevention trial of the German Hypertension League[J]. J Hypertens, 2008, 26(7):1487-1496.
|
17. |
Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker[J]. N Engl J Med, 2006, 354(16):1685-1697.
|